Infantile Type Sandhoff Disease with Striking Brain MRI Findings and a Novel Mutation

Mehtap Beker-Acay1, Muhsin Elmas2, Resit Koken3

  • 1Department of Radiology, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey.

Abstract

Insights

Sandhoff disease, a neurodegenerative disorder, involves GM2 ganglioside accumulation due to beta-hexosaminidase deficiency. Early neuroimaging findings are crucial for diagnosing and managing this condition in infants.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • Sandhoff disease is an autosomal recessive disorder caused by beta-hexosaminidase deficiency.
  • This deficiency leads to the accumulation of ganglioside GM2 and other glycolipids within lysosomes.
  • The disease manifests with progressive motor neuron dysfunction, often resulting in respiratory failure and infections in infants.

Observation:

  • A 22-month-old girl with infantile Sandhoff disease presented with generalized seizures and psychomotor retardation.
  • Diagnostic evaluation included genetic confirmation of a novel mutation.
  • Specific neuroimaging findings associated with the condition were documented.

Findings:

  • The case highlights a novel mutation causing Sandhoff disease.
  • Characteristic neuroimaging findings were identified in the patient.
  • These findings correlate with GM2 gangliosidosis, a lysosomal storage disorder.

Implications:

  • Identifying specific neuroimaging changes is vital for early diagnosis of GM2 gangliosidosis.
  • Neuroimaging serves as an initial diagnostic tool in infants with suspected neurodegenerative diseases.
  • Accurate diagnosis and follow-up are essential for managing Sandhoff disease and similar lysosomal storage disorders.

Related Concept Videos